Revenue growth slowed to 2% YoY, but gross margin improvement of 590 bps and narrowing of the full-year guidance range suggest operational discipline. Watch Q4 for whether the margin trajectory can sustain and if revenue growth reaccelerates toward the high end of guidance.
Price Chart
Executive Summary
Gross margin expanded 590 bps to 59%, but net loss widened to $6.1M from $5.5M a year ago. The company narrowed full-year 2026 revenue guidance to $208M-$211M, maintaining the midpoint.
Key Financial Metrics
Key Facts
- Q3 2026 total revenue $53.2M, up 2% YoY from $52.3M
- GAAP gross margin 59%, up 590 bps from 53% in Q3 2025
- Adjusted gross margin 61%, up from 55%
- Net loss $6.1M vs $5.5M in Q3 2025
- Adjusted EBITDA $0.7M vs $2.5M in Q3 2025
- Full-year 2026 revenue guidance narrowed to $208M-$211M, midpoint maintained
- Installed base grew to 4,073 instruments, adding 140 units in Q3
- Recurring revenue (service + reagent) $19.1M, 36% of total on TTM basis
- Cash, equivalents and marketable securities $256.3M as of Sep 30, 2026
Financial Impact
Revenue $53.2M vs $52.9M consensus; GAAP EPS -$0.05 vs -$0.07 consensus; gross margin expansion of 590 bps
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Product | $37.2M | -2.5% |
| Service | $16.1M | +13.3% |
Risk Factors
- Revenue growth decelerated to 2% YoY from 6% in Q1 2026, signaling potential demand headwinds
- Net loss widened to $6.1M from $5.5M a year ago
- Adjusted EBITDA declined to $0.7M from $2.5M in Q3 2025
- General and administrative expenses rose 14% YoY due to litigation costs
- Product revenue declined 2.5% YoY ($37.2M vs $38.1M)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-447300 |
| Document: d186499d8k.htm | 0001193125-26-447300 |
| Document: 0001193125-26-447300-index-headers.html | 0001193125-26-447300 |
| Document: 0001193125-26-447300-index.html | 0001193125-26-447300 |
| Document: 0001193125-26-447300.txt | 0001193125-26-447300 |
| 8-K Data (Synthetic) | 0001193125-26-447300 |
Track record
14 reports on CTKB
1 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +1.49% at T+1 after the Jun 11, 2026 report. 1 of 3 went positive at some point.
Filters
- Nov 16, 20261d ago ITC Section 337 Neutral 3/10 Entry $5.78 Now $5.63 −2.60% settles Nov 18
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $5.84 to $5.63 Now $5.63 −3.60% ▼ −3.60% −1.68% vs SPY
- Nov 10, 20266d ago Institutional Cluster Bullish 4/10 Entry $5.79 to $5.76 Now $5.63 −2.76% ▼ −0.52% −1.84% vs SPY
- Nov 4, 202612d ago 8-K Neutral 4/10 Viewing No price data
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $5.40 to $5.83 Now $5.63 +4.26% ▲ +7.96% +7.65% vs SPY
- Nov 3, 202613d ago SC 13G/A Neutral 2/10 Entry $5.88 to $5.40 Now $5.63 −4.25% ▼ −8.16% −3.75% vs SPY
- Oct 21, 202626d ago Press Release Neutral 1/10 Entry $5.43 to $5.59 Now $5.63 +3.68% ▲ +2.95% +3.47% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $5.71 to $5.68 Now $5.63 −1.40% ▼ −0.53% +0.19% vs SPY
- Aug 24, 202612w ago 8-K Bearish 7/10 Entry $4.44 to $4.58 Now $5.63 −26.80% ▼ −3.15% −2.83% vs SPY
- Jun 25, 202620w ago 8-K Neutral 2/10 Entry $4.48 to $4.34 Now $5.63 +25.67% ▼ −3.13% −4.77% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers